Neonatal Bilirubin (WG-NB) in cooperation with IFCC Emerging Technologies Division - ETD

Membership

Terms of Reference

1. To understand the current status of agreement in neonatal bilirubin determination against clinical decision levels and EQA performance 
2. To define appropriate performance parameters to ensure fitness for clinical purpose (screening, diagnosing or monitoring)              
3. To review the availability and appropriateness of current JCTLM listed and other CRMs, RMPs and RMSs, define the appropriate measurand(s) and consider appropriate traceability chains
4. To periodically review emerging methodologies, their fitness for purpose and recommend solutions to improve comparability and traceability
5. To collaborate with major manufacturers (from both traditional and near-patient technologies) on neonatal jaundice testing to improve comparability and traceability (where appropriate)
6. To develop and disseminate publications and educational resources related to neonatal jaundice testing for stakeholders to support best practice

Current Projects

• Investigate the six terms of reference to inform strategies for improving alignment of neonatal bilirubin
• Collaboration between the SD and ETD in order to improve the standardisation of neonatal total bilirubin testing for current and emerging tests.

List of Corresponding Members, nominated by National Societies 

List of Corresponding Members, nominated by Corporate Members 

Working Group Chairs contact